Needham reiterates Buy rating on Ocular Therapeutix, $18 price target

Needham reiterated their Buy rating on Ocular Therapeutix's stock with a price target of $18.00.The price target implies an upside of 135.1% from the Sep 28 close of $7.66.Key takeaways from the analyst noteStrong Clinical Data: Ocular Therapeutix's recent Phase 3 trial results for Zenkuda have exc…